Gestational trophoblastic disease


Published on

Published in: Health & Medicine, Technology
1 Comment
No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Gestational trophoblastic disease

  1. 1. Gestational trophoblastic disease Shahin Hameed
  2. 2. Synopsis Introduction  Definition  Classification  Epidemiology  Etiology  Clinical features  Imaging  Tumour spread & staging  Prognostic factors
  3. 3. Synopsis Hydatidiform mole  Complete mole  Partial mole  Invasive mole  Metastatic mole Trophoblastic tumors (neoplastic)  Gestational choriocarcinoma  Placental site trophoblastic tumor  Epithelioid trophoblastic tumor
  4. 4. Synopsis Trophoblastic tumor like lesion (benign)  Placental site nodule  Exaggerated placental site Summary References
  5. 5. Introduction
  6. 6. Definition .. Gestational trophoblastic disease constitutes a diverse group of lesions that includes abnormally formed placentas (hydatidiform moles), benign nonneoplastic lesions, and gestational trophoblastic neoplasms
  7. 7. Epidemiology Gestational trophoblastic disease (GTD) varies widely among various populations As high as 1 in 120 pregnancies in some areas of Asia and South America
  8. 8.  The incidence of hydatidiform moles is greater in women older than 40 years and is also increased in those younger than 20 years. Patients who have had prior GTD are more at risk of having a second GTD after subsequent pregnancies. Other risk factors include: a diet low in vitamin A, lower socioeconomic status and blood group A women married to group 0 men
  9. 9. Aetiology Hydatiform moles arise from abnormal conceptions. Partial moles result from diandric triploidy, whereas complete moles result from diandry (fertilization of an empty ovum) Up to 50% of choriocarcinomas and 15% of placental site trophoblastic tumours follow complete moles
  10. 10. Clinical features A complete molar pregnancy - first trimester bleeding, a uterus larger than expected for gestational age and the absence of fetal parts on ultrasound in association with a markedly elevated beta-human chorionic gonadotropin (b- hCG) level Other signs include hyperemesis, toxaemia during the first or second trimester, theca lutein cysts and hyperthyroidism.
  11. 11.  Patients with partial molar gestations-spontaneous abortions, sometimes with increased b-hCG levels. GTD should always be considered when a patient has continued vaginal bleeding following delivery or abortion.
  12. 12. Imaging A characteristic pattern of multiple vesicles (snowstorm pattern) is commonly seen with complete molar pregnancy. The diagnosis of partial molar pregnancy by ultrasonography is more difficult.
  13. 13. Tumour spread and staging Choriocarcinoma spreads haematogenously and may involve the lung (57-80%), vagina (30%), pelvis (20%), brain (17%), and liver (10%) Since b-hCG titres accurately reflect the clinical disease, histological verification is not required for diagnosis. Staging should be based on history, clinical examination and appropriate laboratory and radiological studies.
  14. 14.  Metastatic GTD is categorized by the WHO scoring system as low, medium and high risk The individual scores for each prognostic factor are added together to obtain a total score A total prognostic score less than or equal to 4 is considered low risk, a total score of 5-7 is considered middle risk, and a total score of 8 or greater is considered high risk
  15. 15. Somatic genetics Overexpression of TP53 protein more commonly observed in complete moles and choriocarcinoma Overexpression of the p21 gene has also been detected in complete moles and choriocarcinoma
  16. 16.  Both complete mole and choriocarcinoma exhibit overexpression of several growth factors including c-Myc, epidermal growth factors receptor (EGFR), c-erbB-2, Rb, mdm2, and bcl-2 as compared to normal placenta and partial mole Strong immunostaining of c-erbB-3 and epidermal growth factor receptor in extravillous trophoblast of complete mole was significantly correlated with the development of persistent gestational trophoblastic tumour
  17. 17. Prognosis and predictivefactors Major adverse prognostic variables for GTD are:(1) Age >39(2) Prior term pregnancy(3) Interval from antecedent pregnancy of >12months(4) b-hCG >105 IU/litre(5) Tumour mass >5cm(6) Disease in liver and brain(7) Failure of 2 or more prior chemotherapies
  18. 18. Hydatidiform moles
  19. 19. Definition An abnormal placenta with villous hydrops and variable degrees of trophoblastic proliferation.
  20. 20. Complete hydatidiform mole A hydatidiform mole involving most of the chorionic villi and typically having a diploid karyotype
  21. 21. Histopathology The villous hydrops of a complete mole is characterized by extensive cavitation. The trophoblastic proliferation has a circumferential distribution, hyperplasia and cytological atypia . Intermediate trophoblast of the molar implantation site characteristically displays marked cytologic atypia A gestational sac, amnion, umbilical cord and fetal tissue are not found
  22. 22.  Recently been suggested that villous stromal nuclear negative staining for the paternally imprinted gene product p57 maybe diagnostically useful for confirming the diagnosis of a complete mole
  23. 23.  Although villous cavitation may be minimal in an "early" mole, other characteristic villous stromal features are present, including hypercellularity and a myxoid basophilic stroma In addition, unusual villous shapes with complex bulbous protrusions ("cauliflower like" villi) and trophoblastic atypia are present
  24. 24. Somatic genetics Complete moles generally have a 46,XX karyotype, and the molar chromosomes are completely of paternal origin Most complete moles appear to arise from an anuclear empty ovum fertilized by a (23X) haploid sperm that then replicates its own chromosomes
  25. 25.  About 10% of complete moles have a 46,XY karyotype The 46,XY complete mole arises from fertilization of an anuclear empty egg by two sperm. While all chromosomes in a complete mole are entirely of paternal origin, the mitochondrial DNA is of maternal origin
  26. 26. Partial hydatidiform mole A hydatidiform mole having two populations of chorionic villi, one of normal size and the other hydropic, with focal trophoblastic proliferation. The lesion typically has a triploid karyotype
  27. 27. Histopathology Histologically, partial moles are characterized by the concurrence of four features(1) Two populations of villi, one hydropic and one"normal"(2) Minimal trophoblastic hyperplasia involvingsyncytiotrophoblast.(3) Enlarged cavitated villi.(4) Other villi with scalloped borders, oftencontaining trophoblastic inclusions.
  28. 28.  Stromal blood vessels often contain nucleated fetal red blood cells; other evidence suggesting fetal development including portions of the chorionic sac wall, amnion, umbilical cord and embryonic/fetal tissue are common
  29. 29. Differential diagnosis(1) Complete mole.(2) Hydropic abortus .(3) Several rare sporadic genetic syndromes suchas the Beckwith-Weidemann syndrome andplacental angiomatous malformation whichcollectively have been termed "placentalmesenchymal dysplasia"
  30. 30. Somatic genetics Partial moles generally have a triploid karyotype that results from fertilization of an apparently normal ovum by two sperm When fetuses are identified with partial moles, they usually have stigmata of triploidy including multiple congenital anomalies and growth retardation
  31. 31. Invasive hydatidiform mole Invasive hydatidiform mole is defined as villi of hydatidiform mole within the myometrium or its vascular spaces. A clinical diagnosis of invasive mole can be suspected when β-hCG titers plateau or increase following evacuation of a mole
  32. 32. Pathologic Features .. Grossly, invasive mole in the uterus results in an irregular, often hemorrhagic lesion that penetrates into the myometrium. The lesion can grow through the myometrium, perforating the serosa or extending into the broad ligament and adnexa Most invasive moles follow complete hydatidiform mole and have the characteristic histological appearance of that lesion.
  33. 33. Metastatic hydatidiform mole Metastatic hydatidiform mole is defined as extrauterine molar villi within blood vessels or tissues, most commonly the vagina or the lung.
  34. 34. Trophoblastic tumours(neoplastic)
  35. 35. Gestational choriocarcinomaA malignant neoplasm composed of large sheets ofbiphasic, markedly atypical trophoblast withoutchorionic villi
  36. 36.  Gestational choriocarcinoma may occur subsequent to a molar pregnancy (50% of instances), an abortion (25%), a normal gestation (22.5%) or an ectopic pregnancy (2.5%) In rare cases an intraplacental choriocarcinoma is diagnosed immediately following pregnancy from placental pathological examination
  37. 37. Morphology The choriocarcinoma is classically a soft, fleshy, yellow-white tumor with a marked tendency to form large pale areas of ischemic necrosis, foci of cystic softening, and extensive hemorrhage
  38. 38. Histopathology The classic pattern of choriocarcinoma has been described as bilaminar, dimorphic, or biphasic. Alternating arrangement of mononucleate trophoblastic cells and syncytiotrophoblastic cells that characterize choriocarcinoma.
  39. 39.  The intermediate trophoblast in choriocarcinoma may show marked variation in the degree of cytologic atypia . Nuclear pleomorphism and hyperchromasia often are striking, and nucleoli can be prominent.
  40. 40.  Vascular invasion often is prominent. Chorionic villi are not a component of choriocarcinoma Choriocarcinoma lacks the intrinsic endothelium- lined vascular channels in the center of a tumor, making it a unique malignant solid tumor.
  41. 41. Immunoprofile All trophoblastic cell types are strongly immunoreactive for cytokeratins Inaddition, the syncytiotrophoblast is strongly immunoreactive for b-hCG and weakly immunoreactive for human placental lactogen (hPL) Intermediate trophoblast shows the opposite immunoprofile
  42. 42. Treatment Includes evacuation of the contents of the uterus, surgery, and chemotherapy. Chemotherapy consists of the administration of one or more of a group of drugs including methotrexate, actinomycin D, and etoposide. The results of chemotherapy for gestational choriocarcinoma are spectacular and have resulted in up to 100% cure or remission in all patients except some who had high-risk metastatic trophoblastic disease.
  43. 43. Differential diagnosis The differential diagnosis of choriocarcinoma in endometrial curettings includes  previllous trophoblast from an early gestation  persistent molar tissue following hydatidiform mole  placental site trophoblastic tumour  epithelioid trophoblastic tumour  undifferentiated carcinoma.
  44. 44. Somatic genetics Recent studies using cDNA microarray analysis have demonstrated decreased expression of heat shock protein-27 in choriocarcinoma, a finding which has been associated with chemotherapy responsiveness in other cancers
  45. 45. Placental site trophoblastic tumour A monophasic neoplasm composed of intermediate trophoblast and cytotrophoblast without a significant component of syncytiotrophoblast
  46. 46.  PSTTs comprise less than 2% of gestational trophoblastic neoplasms and present as neoplastic polygonal cells infiltrating the endomyometrium. PSTTs may be preceded by a normal pregnancy (one-half), spontaneous abortion (one-sixth), or hydatidiform mole (one-fifth)
  47. 47. Histopathology The tumour cells are medium to large sized and mononuclear or multinucleated with mild to marked nuclear atypia, prominent nucleoli, eosinophilic to clear cytoplasm, scattered mitoses and occasional intranuclear inclusions They permeate the myometrium and vessels in a manner reminiscent of the implantation site trophoblast.
  48. 48. Differential diagnosis The differential diagnosis of placental site trophoblastic tumour includes  Placental site nodule  Exaggerated implantation site  Epithelioid leiomyosarcoma  Epithelioid trophoblastic tumour  Poorly differentiated carcinoma . Extensive sampling and immunohistochemistry for keratin, b-hCG and hPL are helpful in distinguishing among the above lesions
  49. 49. Somatic genetics A Y- chromosomal locus and/or new (paternal) alleles not present in adjacent normal uterine tissue was demonstrated in all cases of placental site trophoblastic tumour studied confirming the placental origin of these neoplasms
  50. 50. Prognosis and predictive factors Patients with localized (Stage I or II) disease or a less than 2-year interval from the prior pregnancy to diagnosis have an excellent prognosis. Tumors diagnosed 4 or more years following pregnancy, with lung involvement or with advanced stage have a poor prognosis. An elevated mitotic index predicts a poor outcome
  51. 51. Epithelioid trophoblastic tumour A tumour composed of a monomorphic population of intermediate trophoblastic cells closely resembling those of the membranous chorion
  52. 52. Histopathology Tumour cells of the epithelioid trophoblastic tumour are smaller and less pleomorphic and grow in a nodular pattern
  53. 53.  Because they are frequently found in the cervix, they may be confused with hyalinizing squamous cell carcinomas . Epithelioid trophoblastic tumours are focally immunoreactive for placental-like alkaline phosphatase (PLAP) and hPL but strongly and diffusely immunoreactive for E-cadherin and epidermal growth factor receptor
  54. 54. Somatic genetics A Y-chromosomal locus and/or new (paternal) alleles not present in adjacent normal uterine tissue was demonstrated in all cases of epithelioid trophoblastic tumour studied
  55. 55. Prognosis and predictive factors Based on available data, the behaviour of epithelioid trophoblastic tumour resembles that of placental site trophoblastic tumour.
  56. 56. Trophoblastic tumours like lesions(benign)
  57. 57. Placental site nodule or plaque The placental site nodule or plaque is a well circumscribed lesion with abundant hyalinized stroma infiltrated by scattered, degenerated- appearing intermediate trophoblastic cells that are normally located on the fetal membrane These cells show no significant cytological atypia, but rare mitoses may be present
  58. 58. Pathologic Features Microscopically, the placental site nodule has a discrete, well-circumscribed, lobulated border sometimes showing small irregular nests of cells projecting into the surrounding tissue. Cluster of hyperchromatic and vacuolated chorionic type intermediate trophoblast cells embedded in hyaline matrix
  59. 59. Immunohistochemistry Strongly and diffusely positive for low-molecular- weight cytokeratin (CK; such as CK8/18) Only focally positive for human placental lactogen (hPL) and CD146 (Mel-CAM) Negative for mucin-4
  60. 60.  The chorionic-type intermediate trophoblastic cells in placental site nodules are positive for p63 There is a low level of proliferation in the cells of placental site nodules as indicated by a few scattered Ki-67 labeled nuclei
  61. 61. Differential Diagnosis Small size, circumscription, extensive eosinophilic extracellular matrix, and paucity of mitotic figures distinguish this lesion from PSTT, ETT, and cervical squamous carcinoma The Ki-67 index in ETTs is significantly higher (>10%) than in placental site nodules (<10%).
  62. 62. Exaggerated placental site Exaggerated placental site is a benign, nonneoplastic lesion characterized by an increased number of implantation site intermediate trophoblastic cells that extensively infiltrate the endometrium and underlying myometrium. No specific treatment or follow-up is necessary
  63. 63. Differential Diagnosis Exaggerated placental site may be difficult to distinguish from PSTT, particularly in curetting The presence of chorionic villi (and/or fetal parts) and abundant multinucleated intermediate trophoblastic cells and the absence of confluence of intermediate trophoblastic cells in the endomyometrium suggest the diagnosis of an exaggerated placental site rather than a PSTT.
  64. 64.  The Ki-67 nuclear labeling index using a Ki-67- specific (MIB-1) antibody is superior to the mitotic index as a diagnostic aid in the differential diagnosis of exaggerated placental site versus PSTT . Specifically, the Ki-67 index of the trophoblastic cells in an exaggerated placental site is near zero in contrast to 14% ± 6.9% in a PSTT
  65. 65. Summary Various forms of gestational trophoblastic disease can be defined and related to discrete pathologic aberrations occurring at different trophoblastic subpopulations and stages of trophoblastic differentiation during placentation The recognition and separation of the individual categories of gestational trophoblastic disease are important because each disease entity has distinctive clinical manifestations and each requires different therapeutic approaches
  66. 66. References Lora Hedrick Ellenson, Edyat C Pirog. Female genital tract. Robbins & Cotran’s Pathologic Basis of Disease 2010;8;1057-1061 D.R Genest, R.S Berkpwitz. Gestational trophoblastic disease. Pathology & Genetics of breast & female genital organ WHO;2008;250- 254 Le Ming Shih, Micheal T Mazur. Female reproductive system and peritoneum. Gestational trophoblastic disease. Sternberg’s Diagnostic Surgical Patholgy;2;5;2049-2068 Rosai & Ackerman’s Surgical Pathology. Gestational trophoblastic disease;2;9;1740-1749
  67. 67. Thank you ..